Point/counterpoint. Proton therapy is too expensive for the minimal potential improvements in outcome claimed.

Schulz, Robert J; Smith, Alfred R; Orton, Colin G

Schulz, Robert J; Smith, Alfred R; Orton, Colin G.

Affiliation

Schulz RJ; Yale University, Johnson, Vermont 05656, USA. schulz@pshift.com

Med Phys ; 34(4): 1135-8, 2007 Apr.

Article in En | MEDLINE | ID: mdl-17500444

Subject(s)

Delivery of Health Care/economics; Health Care Costs; Neoplasms/economics; Neoplasms/radiotherapy; Proton Therapy; Radiotherapy, High-Energy/economics; Cost-Benefit Analysis; Humans; Outcome Assessment, Health Care/economics; Outcome Assessment, Health Care/methods; United States

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Health Care Costs / Radiotherapy, High-Energy / Delivery of Health Care / Proton Therapy / Neoplasms Limits: Humans Country/Region as subject: America do norte Language: En Journal: Med Phys Year: 2007 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links